Dr. Rachel Riechelmann is a medical oncologist, clinical scientist, and internationally recognized leader in neuroendocrine tumors (NET) and gastrointestinal cancers. Based in Brazil, she integrates clinical excellence, translational research, and global guideline development, with a strong focus on improving outcomes and access to care in oncology.
Current Position
- Director, Clinical Oncology Department, AC Camargo Cancer Center
- Clinical Scientist, AC Camargo Cancer Center
- Postgraduate Professor in Oncology
Education
- PhD in Oncology, University of São Paulo
- Fellowship in Clinical Cancer Research, Princess Margaret Hospital, Canada
- Medical Oncology Fellowship, Federal University of São Paulo
Areas of Specialization
- Neuroendocrine tumors (NET)
- Gastrointestinal cancers (colorectal and anal cancer)
- Translational oncology and biomarker-driven research
- Oncology clinical trials and drug development
- Multidisciplinary cancer care and program leadership
- Guideline development and evidence-based oncology
Clinical & Research Focus
- Translational research in neuroendocrine tumors
- Optimization of treatment strategies and patient access
- Clinical trial design, execution, and operational leadership
- Multidisciplinary oncology program development
- International collaborative oncology research
Leadership & Institutional Impact
- Leads a department of 36 medical oncologists and 50 oncology fellows
- Directed the creation of 12 multidisciplinary cancer-specific Reference Centers
- Founder and Director of Brazil’s first Neuroendocrine Tumor Reference Center
- Former Coordinator, Clinical Research Unit, Cancer Institute of São Paulo
Global Leadership & Guidelines
- Former President (two terms), Brazilian Gastrointestinal Tumors Group
- Contributor to European Neuroendocrine Tumor Society (ENETS) guideline for carcinoid syndrome
- Contributor to American Society of Clinical Oncology (ASCO) guideline for anal cancer
- Developer of Brazil’s first national guideline for NET (2017)
- Faculty member, European Society for Medical Oncology (ESMO)
Academic Profile
- Author of 160+ peer-reviewed publications in leading journals
- Author of 20+ book chapters
- Editor of Methods and Biostatistics in Oncology (Springer, 2018)
- Associate Editor for multiple international oncology journals
Innovation & Research Contribution
- Principal investigator in translational and clinical research in NET
- Research funded by national agencies, institutional grants, and industry
- Established international collaborations across Latin America, North America, and Europe
Teaching & Mentorship
- Mentor of oncology fellows and PhD students
- Postgraduate teaching in oncology and clinical research
- Advocate for leadership development among women and early-career oncologists
Professional Memberships & Roles
- Faculty, European Society for Medical Oncology (ESMO)
- Member, Common Sense Oncology initiative
- Active contributor to Latin American and Brazilian oncology societies
Notable Roles
Track Leader (Neuroendocrine Tumors), European Society for Medical Oncology (ESMO) Congress 2025
All information is sourced from publicly available materials.